Table 2.
Group | IL-2 (pg/mL) | IL-6 (pg/mL) | IFN-γ (pg/mL) |
---|---|---|---|
NC | 58.2 ± 2.7b | 33.2 ± 1.1c | 82.3 ± 3.2b |
MC | 34.4 ± 2.5a | 15.4 ± 1.2a | 60.1 ± 2.8a |
PC | 64.5 ± 1.3c | 31.4 ± 1.7c | 87.5 ± 3.7bc |
KLDS1.0318-L | 59.3 ± 1.7b | 20.7 ± 1.6b | 92.4 ± 2.9c |
KLDS1.0318-M | 71.7 ± 2.2d | 32.8 ± 2.1c | 102.4 ± 4.1d |
KLDS1.0318-H | 79.6 ± 2.3e | 37.4 ± 1.9d | 123.5 ± 2.5e |
NC, non-immunosuppression + sterilized PBS; MC, immunosuppression + sterilized PBS; PC, IM + levamisole hydrochloride (40 mg/kg); KLDS1.0318-L, IM + 5 × 107 CFU/mL L. plantarum KLDS1.0318; KLDS1.0318-M, IM + 5 × 108 CFU/mL L. plantarum KLDS1.0318; KLDS1.0318-H, IM + 5 × 109 CFU/mL L. plantarum KLDS1.0318. Data are expressed as the mean ± SD (n = 15). Significant differences (p < 0.05) between the groups are indicated with different letters above the data.